ACLARION, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
ACLARION, INC. (ACON) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 0 shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2026-05-13
- ACLARION, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2026-03-31 was 0.00 shares.
- ACLARION, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-12-31 was 0.00 shares.
- ACLARION, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-09-30 was 0.00 shares.
- ACLARION, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-06-30 was 0.00 shares.
- ACLARION, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2025 was 0.00 shares.
- ACLARION, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2024 was 0.00 shares.
- ACLARION, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
- ACLARION, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2022 was 33.33K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-13 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-13 | 0.00 shares derived: sum of 3 quarters · filed 2026-05-13 | 0.00 shares derived: sum of 4 quarters · filed 2026-05-13 | |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-18 | 0.00 shares derived: sum of 3 quarters · filed 2026-03-18 | 0.00 shares 10-K · filed 2026-03-18 | |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-12 | 0.00 shares 10-Q · filed 2025-11-12 | 0.00 shares derived: sum of 4 quarters · filed 2025-11-12 | |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 0.00 shares 10-Q · filed 2025-08-14 | 0.00 shares derived: sum of 3 quarters · filed 2025-08-14 | 0.00 shares derived: sum of 4 quarters · filed 2025-08-14 | |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-15 | 0.00 shares derived: sum of 2 quarters · filed 2025-05-15 | 0.00 shares derived: sum of 3 quarters · filed 2025-05-15 | 0.00 shares derived: sum of 4 quarters · filed 2025-05-15 | |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-09 | 0.00 shares derived: sum of 2 quarters · filed 2025-04-09 | 0.00 shares derived: sum of 3 quarters · filed 2025-04-09 | 0.00 shares 10-K · filed 2025-04-09 | |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-14 | 0.00 shares 10-Q · filed 2024-11-14 | 0.00 shares derived: sum of 4 quarters · filed 2025-04-09 | |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 0.00 shares 10-Q · filed 2024-08-14 | 0.00 shares derived: sum of 3 quarters · filed 2025-04-09 | 0.00 shares derived: sum of 4 quarters · filed 2025-04-09 | |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-15 | 0.00 shares derived: sum of 2 quarters · filed 2025-04-09 | 0.00 shares derived: sum of 3 quarters · filed 2025-04-09 | 0.00 shares derived: sum of 4 quarters · filed 2025-04-09 | |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-09 | 0.00 shares derived: sum of 2 quarters · filed 2025-04-09 | 0.00 shares derived: sum of 3 quarters · filed 2025-04-09 | 0.00 shares 10-K · filed 2025-04-09 | |
| 2023-09-30 | 0.00 shares 10-Q · filed 2023-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2023-11-14 | 0.00 shares 10-Q · filed 2023-11-14 | -496.29K shares derived: sum of 4 quarters · filed 2024-03-28 | |
| 2023-06-30 | 0.00 shares 10-Q · filed 2023-08-25 | 0.00 shares 10-Q · filed 2023-08-25 | -496.29K shares derived: sum of 3 quarters · filed 2024-03-28 | ||
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-07-03 | -496.29K shares derived: sum of 2 quarters · filed 2024-03-28 | |||
| 2022-12-31 | -496.29K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 33.33K shares 10-K · filed 2024-03-28 | 533.35K shares 10-K · filed 2023-02-27 | ||
| 2022-09-30 | 529.62K shares 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |